The co-cultivation system revealed that DCs present tumor-specific antigens to CTLs and induce PD-1 expression on these lymphocytes, at the same time tumor cells express inhibitor of CTL function—programmed cell death ligand 1 (PD-L1) that leads to protection of cancer cells from anti-tumor lymphocyte activity [77]. This evidence concerns the gene CD274 and neoplasm.